BiOptic (ROCO:6850) Construction In Progress: NT$0.0 Mil (As of Dec. 2025)


ROCO:6850 BiOptic Inc ROCO:6850
92 GF Score
Price NT$34.00
GF Value NT$44.90
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BiOptic Construction In Progress?

BiOptic ROCO:6850 92 Construction In Progress is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6850 with a GF Score™ of 92/100 and a GF Value™ of NT$44.90 (Modestly Undervalued). The stock has 4 warning signs investors should review.

BiOptic Construction In Progress Historical Data

* Premium members only.

The historical data trend for BiOptic's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BiOptic Construction In Progress Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6850
92GF Score
BiOptic Inc ROCO:6850
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BiOptic Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of NT$0.0 Mil mean?
BiOptic (ROCO:6850) has a Construction In Progress of NT$0.0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on BiOptic and its competitors.
Is BiOptic's Construction In Progress too high?
BiOptic's current Construction In Progress is NT$0.0 Mil. Overall, BiOptic has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BiOptic's Construction In Progress compare to VRTX and REGN?
BiOptic's Construction In Progress of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on BiOptic and its competitors. BiOptic's current Construction In Progress is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BiOptic stock overvalued right now?
Based on GuruFocus' analysis, BiOptic (ROCO:6850) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$44.90, compared to a current price of NT$34.00 — trading 24.3% below its estimated fair value. The current Construction In Progress is NT$0.0 Mil. BiOptic's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For BiOptic (ROCO:6850), the current Construction In Progress is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BiOptic (ROCO:6850) Overvalued in 2026?

Based on GuruFocus' analysis, BiOptic stock appears to be undervalued. The current stock price of NT$34.00 is trading 24.3% below its estimated GF Value™ of NT$44.90. GuruFocus considers BiOptic to be Modestly Undervalued.

Key valuation signals for ROCO:6850:

  • Construction In Progress: NT$0.0 Mil
  • GF Value™: NT$44.90 vs. price of NT$34.00 (24.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6850 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BiOptic Business Description

Address No. 108-3, Minquan Road, 4th Floor, Xindian District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.
92GF Score

Get the complete analysis for ROCO:6850

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.00
Price
NT$44.90
GF Value